BioLineRx (BLRX) Accumulated Expenses (2016 - 2020)

BioLineRx's Accumulated Expenses history runs 5 years deep, the most recent figure standing at $884000.0 for Q4 2020.

• In Q4 2020, Accumulated Expenses rose 21.6% year-over-year to $884000.0; the TTM figure through Dec 2020 stood at $884000.0 (up 21.6% YoY), while the FY2020 annual figure was $884000.0, up 21.6% from the prior year.
• Accumulated Expenses for Q4 2020 stood at $884000.0, up from $727000.0 in the prior quarter.
• The five-year high for Accumulated Expenses was $884000.0 in Q4 2020, with the low at $560000.0 in Q4 2016.
• The 5-year median for Accumulated Expenses is $727000.0 (2019), against an average of $716600.0.
• The sharpest annual moves came in 2018 and 2019: Accumulated Expenses rose 27.74% in 2018, then fell 8.21% in 2019.
• BioLineRx's Accumulated Expenses stood at $560000.0 in 2016, then rose by 10.71% to $620000.0 in 2017, then climbed by 27.74% to $792000.0 in 2018, then dropped by 8.21% to $727000.0 in 2019, then grew by 21.6% to $884000.0 in 2020.
• Business Quant data shows BLRX's Accumulated Expenses at $884000.0 in Q4 2020, $727000.0 in Q4 2019, and $792000.0 in Q4 2018.